• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>MedImmune

MedImmune

  1. All
  2. Morningstar Articles
  3. 3rd Party
  4. Investing
  1. Evotec and Ellersbrook Join Forces to Accelerate TargetNASH

    Evotec and Ellersbrook Join Forces to Accelerate TargetNASH

  2. Global Hairy Cell Leukemia Pipeline Review, H1 2016 - Analysis, Technologies & Forecasts Report - Key Vendors: AstraZeneca, MedImmune , Novartis - Research and Markets

    Global Hairy Cell Leukemia Pipeline Review, H1 2016 - Analysis, Technologies & Forecasts Report - Key Vendors: AstraZeneca, MedImmune , Novartis - Research and Markets

  3. Technavio Announces Top Ten Vendors in the Global Chronic Lymphocytic Leukemia Market from 2016 to 2020

    Technavio Announces Top Ten Vendors in the Global Chronic Lymphocytic Leukemia Market from 2016 to 2020

  4. Sosei Appoints Peter Bains as CEO

    Sosei Appoints Peter Bains as CEO

  5. Global Acute Coronary Syndrome Report 2016 - Pipeline Review of 15 Pharma Companies & Drug Profiles - Research and Markets

    Global Acute Coronary Syndrome Report 2016 - Pipeline Review of 15 Pharma Companies & Drug Profiles - Research and Markets

  6. Durvalumab Monotherapy Demonstrates Efficacy in Urothelial Bladder Cancer

    Durvalumab Monotherapy Demonstrates Efficacy in Urothelial Bladder Cancer

  7. Programmed Cell Death Protein 1 (CD279 or Systemic Lupus Erythematosus Susceptibility 2 or PD1) - Pipeline Review, H1 2016 - Research and Markets

    Programmed Cell Death Protein 1 (CD279 or Systemic Lupus Erythematosus Susceptibility 2 or PD1) - Pipeline Review, H1 2016 - Research and Markets

  8. Evotec to Present at the Jefferies 2016 Global Healthcare Conference (New York)

    Evotec to Present at the Jefferies 2016 Global Healthcare Conference (New York)

  9. Pharmaceutical Firms Get the Urge to Merge

    Morningstar analysts see pharmaceuticals as 2010's hot zone for mergers and acquisitions.

  10. Biotech Investing for the Long Haul

    Three ways to separate long-term winners from stocks that fizzle.

12
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.